Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren
Opioid Epidemic
Policy
Comment: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs
Submitted to U.S. Senate Committee on Finance
Print:
On April 23, 2024, the Leonard Davis Institute of Health Economics Substance Use and Harm Reduction Working Group submitted a statement regarding the United States Senate Committee on Finance’s recent hearing “Closing Gaps in the Care Continuum: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs.” Their comment makes recommendations for improvement in several areas of the care continuum which deserve urgent attention, such as reimbursement for care in a wide range of settings and for certified recovery specialists, improved methadone access, improved wound care and support for harm reduction services.
More on Policy at LDI
Testimony: Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and Treatment
Delivered to the United States Senate Committee on Finance
Comment: Development of a Universal Symbol for Language Assistance Services in Health Settings
Submitted to the Office of Minority Health, U.S. Department of Health and Human Services
Comment: Health Care Market Consolidation and Private Equity Funds
Submitted to U.S. Department of Justice, Department of Health and Human Services, and Federal Trade Commission
Briefing: Addressing U.S. Opioid Epidemic Through Increasing Access to Methadone
Presented to Staff of U.S. House of Representative
Briefing: Addressing U.S. Opioid Epidemic Through Increasing Access to Methadone
Presented to Staff of U.S. Senate Committee on Health, Education, Labor, and Pensions